Category: Treatment

Introduction

The world’s largest medical problem in this century is cancer. The most devastating fact about this life threatening disease is its silent growth in the body. Not only is it difficult for physicians to detect cancer at an early stage, but also, finding the right treatment for the disease is an uphill task. Most cancer patients have lost this battle because, like fire, it consumes all the active and healthy parts of the body’s immunity. With that said, many scientists have taken it upon themselves to study the human body and how cancer cells multiply within the active, healthy cells. One such scientist is Mikhail Blagosklonny.

Know more: http://gettingstronger.org/tag/mikhail-blagosklonny/

TOR Signaling

Mikhail is a scientist. He specializes in the study of cancer and aging. Over the past years, he has been working on finding treatment for cancer through therapies. Following his vast experience in science and age-related disease, Mikhail formulated a hypothesis called TOR Signaling. According to this hypothesis, there is a possibility of TOR Signaling treating cancer. This way, rapamycin will be used, and the result would be beating the aging process hence curbing all age-related disease. To Mikhail, this is the cure for life extension. Mr. Blagosklonny is considered a passionate supporter of rapamycin. He has been an active participant in longevity research.

Education and Career

Blagosklonny’s first education degree was acquired from the University of Petersburg. In this school, he studied internal medicine and earned a PhD in medicine and cardiology. Following his academic credentials, he was appointed the associate professor for a medical college in New York City. In 2002, Mikhail Blagosklonny was trusted with the position of senior scientist in Ordway Institute of Research. This facility is geographically located in Albany, New York. He was responsible for daily operations of the organization until 2009.

After that experience, Blagosklonny landed a huge position at Roswell Institute of Cancer Research. Blagosklonny has been passionate in the field of cancer research. With his scientific knowledge, he develops cancer therapies generating from normally damaged cells. To Blagosklonny, the fight against cancer is on, and the best way around it is investing time and resources towards research. Visit ResearchGate.Net to learn more about Mikhail’s latest work.

A breakthrough in the treatment of multiple sclerosis (MS), a condition where the immune system attacks the central nervous system, may have been found. Stem cell transplantation from one’s blood and a high-dose of immunosuppressive therapy has proven to be working.

In a span of five years, 69% of trial patients who have undergone the treatment of being administered high doses of immunosuppressive therapy, and then carrying out cell transplantation (HDIT/HCT), have survived. No relapse or associated symptoms of the condition have been seen. They have also shown improvement in mobility and other physical capabilities.

National Institute of Allergy and Infectious Disease (NIAID) was backing the trial. Immune Tolerance Network (ITN), was then responsible for carrying out the HALT-MS trial, and Dr. Richard Nash of Colorado Blood Cancer Institute, was its principal investigator. The final results of the five-year study were posted in Neurology, which is a medical journal, on Feb 1, 2017. HDIT/HCT treatment has proven to be far much effective than other forms of MS medication according to the findings.

Patients with MS who don’t respond to other existing forms of medication may undergo HDIT/HCT. The therapy has brought about a long-term solution in the treatment of MS. HDIT/HCT is still under investigation to establish its benefits and risks. Some of the side effects posed by the treatment is a possibility of a blood infection.

About Dr. Shiva

Dr. Shiva Vasishta graduated from Government Medical College Nagpur in 1979. He also attended Boston University Medical Centre as well as Tufts Medical Centre. Dr. Shiva Vasishta is licensed by the American Board of Psychiatry and Neurology as a Neurologist. He has practiced for 38 years, and currently practicing in Voorhees, New Jersey. Dr. Shiva Vasishta is a member of Eastern Neurodiagnostic Association Pc and is affiliated with Kennedy University Hospital. Dr. Shiva Vasishta communicates in both English and Spanish.